Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -169.26x is 208% below its 5-year average of -54.96x, around the middle of its 5-year range (-298.46x–14.24x).
As of the fiscal period ended Thursday, September 30, 2021. 136.56% below its 12-month average of -71.55x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2021 (2021-09-30): -169.26x.
INTEREST COVERAGE RATIO
-169.26x
INTEREST COVERAGE RATIO AVG TTM
-71.55x
INTEREST COVERAGE RATIO AVG 3Y
-78.45x
INTEREST COVERAGE RATIO AVG 5Y
-54.96x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-136.56%
CURRENT VS 3Y AVG
-115.74%
CURRENT VS 5Y AVG
-207.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-2554.99%
vs the sector median at left
Quanterix Corporation
Market Cap
$163.28M
Interest Coverage Ratio
-169.26x
TTM Avg
-71.55x
3Y Avg
-78.45x
5Y Avg
-54.96x
Market Cap
$163.00M
Interest Coverage Ratio
-19.95x
TTM Avg
6.75x
3Y Avg
6.75x
5Y Avg
6.75x
Market Cap
$165.88M
Interest Coverage Ratio
2.28x
TTM Avg
2.28x
3Y Avg
2.28x
5Y Avg
2.28x
Market Cap
$160.03M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$168.97M
Interest Coverage Ratio
-38.13x
TTM Avg
21.71x
3Y Avg
21.71x
5Y Avg
21.71x
Market Cap
$156.90M
Interest Coverage Ratio
N/A
TTM Avg
2247.41x
3Y Avg
1131.54x
5Y Avg
905.57x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quanterix Corporation (QTRX) | $163.28M | -169.26x | -71.55x | -78.45x | -54.96x |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | -19.95x | 6.75x | 6.75x | 6.75x |
| PepGen Inc. (PEPG)vs › | $160.13M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.88M | 2.28x | 2.28x | 2.28x | 2.28x |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.03M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -5.64x | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX)vs › | $165.99M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $168.97M | -38.13x | 21.71x | 21.71x | 21.71x |
| Inogen, Inc. (INGN)vs › | $156.90M | N/A | 2247.41x | 1131.54x | 905.57x |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.84M | N/A | 8.41x | 7.29x | 7.29x |
Interest Coverage
-169.3x
Debt/Equity
0.14
Current Ratio
3.40
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-09-30 | -169.26x |
| 2021-06-30 | -82.84x |
| 2021-03-31 | -60.06x |
| 2020-12-31 | -59.84x |
| 2020-09-30 | 14.24x |
| 2020-06-30 | -112.97x |
| 2018-03-31 | -298.46x |
| 2017-12-31 | -32.69x |
| 2017-09-30 | -26.61x |
| 2017-06-30 | -26.95x |
| 2017-03-31 | -23.75x |
| 2016-12-31 | -23.82x |
